Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Gene|July 12, 2017
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugsAurélie Delacrétaz, Adna Zdralovic, Frederik Vandenberghe, et al.Plos One|December 3, 2020
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medicationLuis Alameda, Axel Levier, Mehdi Gholam-Rezaee, et al.The Journal of Clinical Psychiatry|December 10, 2015
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatmentFrederik Vandenberghe, Mehdi Gholam-Rezaee, Núria Saigí-Morgui, et al.Psychosomatic Medicine|July 3, 2018
Psychosocial Stress Over the Lifespan, Psychological Factors, and Cardiometabolic Risk in the CommunitySirak Zenebe Gebreab, Caroline L Vandeleur, Dominique Rudaz, et al.Translational Psychiatry|July 6, 2021
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohortCéline Dubath, Mehdi Gholam-Rezaee, Jennifer Sjaarda, et al.Plos One|October 14, 2015
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical DepressionAurélie Delacrétaz, Martin Preisig, Frederik Vandenberghe, et al.Journal of Affective Disorders|July 16, 2017
Partially distinct combinations of psychological, metabolic and inflammatory risk factors are prospectively associated with the onset of the subtypes of Major Depressive Disorder in midlifeDominique A Rudaz, Caroline L Vandeleur, Sirak Z Gebreab, et al.Pharmacogenetics and Genomics|March 10, 2015
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatmentsLina Quteineh, Frederik Vandenberghe, Nuria Saigi Morgui, et al.Journal of Psychiatric Research|August 5, 2014
Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based studyJennifer Glaus, Caroline L Vandeleur, Roland von Känel, et al.Depression and Anxiety|December 16, 2017
The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: Results from a large longitudinal population-based studyJennifer Glaus, Roland von Känel, Aurélie M Lasserre, et al.Pageof 4